Mar 20, 2009 - OSI Pharmaceuticals, Inc. announced today that the Company has filed two lawsuits in U.S. District Court in Delaware against Teva Pharmaceuticals USA, Inc. and Mylan Pharmaceuticals, Inc. for infringement of US Patent No. 5,747,498, US Patent No. 6,900,221 and US Patent No. 7,087,613. All three patents are associated with Tarceva (erlotinib).
The details can be read here.
No comments:
Post a Comment